Filing Summary
Business Context and Reporting Period
Fractyl Health, Inc. filed a Form 8-K dated September 24, 2026, reporting the results of its Special Meeting of Stockholders held on that date. The company’s common stock trades on Nasdaq under the symbol GUTS.
Meeting Participation and Vote
- Common shares outstanding as of the August 21, 2026 record date: 159,179,848.
- Shares represented at the Special Meeting: 111,987,852, or approximately 70.35% of outstanding voting power.
- Votes for: 102,476,581.
- Votes against: 9,319,450.
- Abstentions: 191,821.
Material Corporate Action
Stockholders approved alternate amendments to the Amended and Restated Certificate of Incorporation authorizing the Board of Directors, at its sole discretion, to effect a reverse stock split of the common stock at a ratio ranging from 1-for-5 to 1-for-15, inclusive.
The filing does not state whether the Board has selected a specific ratio or when the reverse stock split will become effective.
Financial Metrics, Guidance, and Risks
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, financial guidance, or management commentary on operating performance. The principal transaction-related consideration is the potential reverse stock split, including uncertainty regarding its final ratio and timing.
Key Facts for Investors to Verify
- Whether and when the Board authorizes the reverse stock split.
- The final reverse stock split ratio, which may range from 1-for-5 to 1-for-15.
- The effective date and treatment of fractional shares, if applicable.
- Any subsequent Nasdaq listing-status or capital-structure implications.